SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NUMD

Nu-Med Plus, Inc. (OTC:NUMD)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$0.01+$0.00 (+0.00%)
 
Market cap
$902K
Insider Score
Health Score
Listed since
Sep 25, 2014
Market Cap$902.32K-55.6%
Revenue (ttm)$0-100.0%
Net Income-$20.79K+65.8%
EPS-$0.00+50.0%
Shares Out83.55M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,000
Open$0.01
Previous Close$0.01
Day's Range$0.01 - $0.01
52-Week Range$0.01 - $0.03
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a
No price history available.

About NUMD

Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such as specialized units for hospital environments, clinical applications, and research settings, alongside a mobile, rechargeable device designed for portable nitric oxide gas administration. Serving a broad spectrum of healthcare entities, its primary clients consist of hospitals, integrated health systems, and the wider medical professional community. Nu-Med Plus, Inc. was founded in 2011 and maintains its corporate headquarters in Salt Lake City, Utah.

Address
640 Belle Terre Road, Port Jefferson, NY, 11777, US
Market Cap
1 million
Employees
2
Industrial Classification
Medical - Devices
Financial Health Score
Distressed
From NUMD’s reported statements · Q2 2026 (trailing 12 months) · 3 of 5 pillars
1 Day
+0.00%
5 Days
+13.68%
1 Month
+50.00%
6 Months
+5.88%
1 Year
-55.61%

$NUMD stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NUMD holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NUMD's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NUMD Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New NUMD patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NUMD from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from NUMD’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.